Restart Life Sciences Corp. (HEAL:CC) | Stock Information | Vox Markets
Vox Markets

Restart Life Sciences Corp.

HEAL:CC

Recent News

CompanyTitleDate
HEALHEAL Restart Life Sciences Announces Dedicated Purchase Order Financing through Private Placement Offering1 day ago
HEALHEAL Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio1 day ago
HEALHEAL Form 9 - Notice of Issuance of Securities1 day ago
HEALHEAL Form 9 - Notice of Issuance of Securities1 day ago
HEALHEAL Restart Life Sciences Appoints Capital Markets Veteran Lindsay Hamelin to Board of Directors2 days ago
HEALHEAL FORM 7 - MONTHLY PROGRESS REPORT3 days ago
HEALHEAL Restart Life Sciences reports Holy Crap Foods revenue gains of 46% in wholesale and 32% via Amazon channels YoY4 days ago
HEALHEAL Restart Life Advances Holy Crap™ Growth Strategy with New Protein SKU Nearing CommercializationApr 30, 2026
HEALHEAL Restart Life Sciences’ Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada’s Digital MarketplaceApr 28, 2026
HEALHEAL FORM 5A - ANNUAL LISTING SUMMARYApr 25, 2026
HEALHEAL Form 52-109FV1 - Certification of annual filings (CFO)Apr 25, 2026
HEALHEAL Form 52-109FV1 - Certification of annual filings (CEO)Apr 25, 2026
HEALHEAL Annual Management Discussion & AnalysisApr 24, 2026
HEALHEAL Audited Consolidated Year End Financial StatementsApr 24, 2026
HEALHEAL Restart Life Sciences’ Wholly Owned Subsidiary Holy Crap Foods Reports Over 500,000 Units Sold, Highlighting Strong Consumer AdoptionApr 23, 2026
HEALHEAL Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand PortfolioApr 22, 2026
HEALHEAL FORM 7 - MONTHLY PROGRESS REPORTApr 2, 2026
HEALHEAL Form 11 - Notice of Proposed Option GrantMar 27, 2026

Overview

Classification

Sector Healthcare

Industry Biotechnology & Life Sciences

Subindustry Biotechnology

Financials